News Daily News FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF Caitlin E. Cox July 14, 2025
News Daily News Acoramidis Approved in Europe for ATTR Cardiomyopathy Michael O'Riordan February 12, 2025
News Daily News FDA Approves First ‘Near-Complete’ Stabilizer to Treat ATTR Cardiomyopathy L.A. McKeown November 25, 2024
News Daily News FDA Approves Cordella Remote PA Pressure Monitoring System for HF Yael L. Maxwell June 24, 2024
News Daily News Biologic Winrevair Wins FDA Approval for Treatment of PAH L.A. McKeown March 27, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024
News Daily News FDA Approves First Transcatheter Tricuspid Valve Replacement Device L.A. McKeown February 02, 2024
News Daily News FDA Grants First HF Indication for IV Iron to Ferric Carboxymaltose Shelley Wood June 05, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Most Patient-Reported Outcome Measures in CVD Fall Short L.A. McKeown September 23, 2022
News Daily News FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy Michael O'Riordan April 29, 2022
News Daily News FDA Approves Empagliflozin for Treatment of HFpEF Michael O'Riordan February 24, 2022
News Daily News FDA Grants Expanded Indication to CardioMEMS PA Pressure Monitor Shelley Wood February 22, 2022